Meth costs rising
This article was originally published in The Tan Sheet
Executive SummaryMeth abuse caused facility costs to increase at 56% of hospitals who responded to a recent survey, the National Association of Counties announced Jan. 18. "The Effect of Meth on Hospital Emergency Rooms" was commissioned by the association in late 2005. The survey also finds that 47% of emergency rooms report meth as the top illicit drug involved in presentation at their hospitals, and 73% of hospitals say that meth-related ER presentations have increased over the last five years. Also, 83% of respondents said that patients presenting with a meth-related emergency are "often uninsured." Washington, D.C.-based Research, Inc. conducted the telephone surveys of 200 ERs in 48 states...
You may also be interested in...
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.
While contract manufacturer ABH Nature' complied with consent decree, Sen. Chuck Schumer says FDA is late in enforcing against noncompliant firms across the supplement sector. Other recent consumer health recalls include more OTC ranitidine tablets due to the potential carcinogen NDMA found in the heartburn ingredient and four versions of Sure 48HR Anti-Perspirant & Deodorant with labeling errors.